Evoq Remedies Ltd Q4FY25 net profit at Rs. 1.71 crore

Evoq Remedies Limited has reported Standalone financial results for the period ended March 31, 2025.

Financial Results (Q4 FY2025) - QoQ Comparison

The company has reported total income of Rs. 14.1607 crores during the period ended March 31, 2025 as compared to Rs. 0.0106 crores during the period ended December 31, 2024.

The company has posted net profit / (loss) of Rs. 1.7126 crores for the period ended March 31, 2025 as against net profit / (loss) of Rs. -1.6244 crores for the period ended December 31, 2024.

The company has reported EPS of Rs. 0.69 for the period ended March 31, 2025 as compared to Rs. -0.65 for the period ended December 31, 2024.

Financials	Q4 FY2025	Q3 FY2025	% Change
Total Income	₹ 14.1607 crs	₹0.0106 crs	133,491.51%
Net Profit	₹1.7126 crs	₹-1.6244 crs	205.43%
EPS	₹0.69	₹-0.65	206.15%

Financial Results (Q4 FY2025) - YoY Comparison

The company has reported total income of Rs. 14.1607 crores during the period ended March 31, 2025 as compared to Rs.2.4064 crores during the period ended March 31, 2024.

The company has posted net profit / (loss) of Rs.1.7126 crores for the period ended March 31, 2025 as against net profit / (loss) of Rs.0.3831 crores for the period ended March 31, 2024.

The company has reported EPS of Rs.0.69 for the period ended March 31, 2025 as compared to Rs.0.28 for the period ended March 31, 2024.

Financials	Q4 FY2025	Q4 FY2024	% Change
Total Income	₹ 14.1607 crs	₹2.4064 crs	488.46%
Net Profit	₹1.7126 crs	₹0.3831 crs	347.04%
EPS	₹0.69	₹0.28	146.43%

Financial Results (Year Ended FY2025) - YoY Comparison

The company has reported total income of Rs.14.1713 crores during the Financial Year ended March 31, 2025 as compared to Rs.6.3090 crores during the Financial Year ended March 31, 2024.

The company has posted net profit / (loss) of Rs.0.0882 crores for the Financial Year ended March 31, 2025 as against net profit / (loss) of Rs.0.4524 crores for the Financial Year ended March 31, 2024.

The company has reported EPS of Rs.0.04 for the Financial Year ended March 31, 2025 as compared to Rs.0.33 for the Financial Year ended March 31, 2024.

Financials	Year Ended FY2025	Year Ended FY2024	% Change
Total Income	₹14.1713 crs	₹6.3090 crs	124.62%
Net Profit	₹0.0882 crs	₹0.4524 crs	-80.50%
EPS	₹0.04	₹0.33	-87.88%

Shares of Evoq Remedies Limited was last trading in BSE at Rs. 2.81 as compared to the previous close of Rs. 2.76. The total number of shares traded during the day was 4000 in over 1 trades.

The stock hit an intraday high of Rs. 2.81 and intraday low of 2.81. The net turnover during the day was Rs. 11240.00.

Source : Equity Bulls

Keywords

EvoqRemedies Q4FY25 Q4FY2025 FY2025 ResultUpdate